Three latest studies explored the new likely medical properties of cannabis and found that cannabis has analgesic and addiction-breaking properties.
The world of medical cannabis is growing month after month, mostly due to the increasing number of research studies in regards to the effects of cannabis on humans.
In what turned out to be perhaps one the more revolutionary medical cannabis studies, Auburn University Ph.D. candidate Julio Yanes conducted an experiment including 66 students of the same university.
The series of experiments he conducted were meant to discern how cannabis use influences pain in users and non-users alike.
Half of the 66 students were admitted cannabis consumers and the other half were non-users.
The experiment was quite harmless. Participants were strapped to an experimental pain apparatus—a band fitted with a plastic disk that applies pressure to a sensitive part of the hand.
They were then instructed to rate the pain on a scale of 0-100, and note the experiment conductors once the pain becomes too strong to proceed with the experiment.
The group of students which were cannabis consumers reported lower levels of pain on average (42) than those that were non-consumers(51).
Cannabis consumers also reported higher maximum pain tolerance than the non-consumers.
More proof to support the pain management claims
The previous experiment only goes further to prove what we already know: Cannabis for pain management is a real thing and not just some snake oil story.
In a review study published by the American Journal of Surgery two researchers confirmed the impact of cannabis on surgical patients.
They found that the active compounds in cannabis (cannabinoids) are responsible for reducing intestinal motility, gastric acid secretion, and nausea.
Cannabinoids also improve pain control, reduce inflammation, and increase appetite, according to the two researchers.
They also noted that medical cannabis and cannabinoids vary in legality from state to state, and country to country, as well as that very few pharmacologic cannabinoids are currently available.
CBD reduces methamphetamine consumption in rodents
In yet another revolutionary study, preliminary findings suggest that cannabidiol could be effectively used to combat meth addictions.
Methamphetamine is a psycho-stimulant, while CBD is known to alleviate the psychotropic effects of THC, meaning that it has the opposing effect and that it calms cannabis users.
The researchers found that treatment with doses between 20 mg/kg and 80 mg/kg of cannabidiol (in other words, extremely high doses, as most humans consume 12 mg of CBD per day in total) reduced the motivation to consume methamphetamine in rats trained to self-administer the addictive stimulant.
However, the rats didn’t respond in the same manner to sucrose, which they also had access to, meaning that the effects are somewhat targeted rather than affecting reward mechanisms in general.
The next step would be to confirm these effects of CBD on meth-addicted humans.
The authors of the study suggested that potential therapeutic benefits of cannabinoids are “great and should be explored to develop targeted therapies for mental health”.